Recent Blog Posts

View Post: Oncolytics Biotech's REOLYSIN combined with paclitaxel and ...
25 Nov 2009 by Syn-chemist  
In continuation of my follow up on cisplatin derivatives, I find this article interesting to share with..... Oncolytics Biotech's REOLYSIN combined with paclitaxel and carboplatin well tolerated for advanced cancers ...
View Blog: Med-Chemist - http://synchemist.blogspot.com/

---

View Post: Stable Angina Clinical Trial: A Trial of Everolimus-eluting Stents ...
16 Nov 2009
Official Title: “A Randomized Controlled Trial of Everolimus-eluting Stents and Paclitaxel-eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial”. Condition Keyword(s): ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: OVARIAN CANCER and US: EvidenceUpdates: Phase III trial of ...
12 hours ago by Sandi Pniauskas  
This article clarifies a terrible doubt of gynecological oncologist: a consolidation treatment with six cycles of paclitaxel does not prolong progression-free survival or overall survival in patients in complete response after ...
View Blog: OVARIAN CANCER and US - http://ovariancancerandus.blogspot.com/

---

View Post: Independent Review of E2100: A Phase III Trial of Bevacizumab Plus ...
16 Oct 2009 by Gray, Bhattacharya, Bowden, Miller, Comis  
Conclusion The risk of progression was reduced by more than half and the ORR more than doubled with the addition of bevacizumab to weekly paclitaxel in both analyses, confirming a substantial and robust bevacizumab treatment effect. ...
View Blog: Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/

---

View Post: Second-line Chemotherapy with Biweekly Paclitaxel after Failure of ...
2 Nov 2009 by Koizumi, W., Akiya, T., Sato, A., Yamaguchi,...  
Second-line Chemotherapy with Biweekly Paclitaxel after Failure of Fluoropyrimidine-based Treatment in Patients with Advanced or Recurrent Gastric Cancer: a Report from the Gastrointestinal Oncology Group of the Tokyo Cooperative ...
View Blog: Japanese Journal of Clinical Oncology -... - http://jjco.oxfordjournals.org/

---

View Post: A phase I trial of paclitaxel and trastuzumab in combination with ...
10 Nov 2009 by Bekaii-Saab, TS, Roda, JM, Guenterberg,...  
We aimed to determine the safety profile of IL-12 when given in combination with trastuzumab and paclitaxel to patients with metastatic HER2-overexpressing cancers. Paclitaxel was given i.v. at 175 mg/m2 every 3 weeks. ...
View Blog: Molecular Cancer Therapeutics current issue - http://mct.aacrjournals.org/

---

View Post: Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting ...
9 Nov 2009 by Maehara, A., Mintz, GS, Lansky, AJ, Witzenbichl...  
Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting and Bare Metal Stents in Acute Myocardial Infarction. The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Intravascular Ultrasound ...
View Blog: Circulation recent issues - http://circ.ahajournals.org/

---

View Post: Evaluation of the Peri-strut Low Intensity Area Following ...
14 Nov 2009
Evaluation of the Peri-strut Low Intensity Area Following Sirolimus- and Paclitaxel-Eluting Background: In previous pathological studies, paclitaxel-eluting stents (PES) showed greater fibrin deposition around stent struts, ...
View Blog: Optical Coherence Tomography News - http://www.octnews.org/

---